RNAC logo

Cartesian Therapeutics (RNAC) CAPEX

Annual CAPEX

$206.00 K
-$995.00 K-82.85%

December 31, 2023

Summary

Performance

1-Year Change

-82.85%

3-Year Change

-74.72%

5-Year Change

-76.7%

15-Year Change

-71.9%

RNAC CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

18.35%
RNAC annual capital expenditures is higher than 18.35% of companies in Healthcare sector

High & Low

All-time High

$1.20 M
RNAC annual capital expenditures is currently -82.85% below its historical high of $1.20 million

3-Year Low

$206.00 K
RNAC annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RNAC previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 7, 2025
RNAC next annual earnings announcement is scheduled for Mar 7, 2025

OtherRNACcash flowmetrics:

Annual FCF

-$51.37 M
RNAC annual free cash flow is -$51.37 million

Annual CFO

-$51.16 M
RNAC annual cash flow from operations is -$51.16 million

Annual CFI

$34.61 M
RNAC annual cash flow from investing activities is $34.61 million

Annual CFF

-$13.14 M
RNAC annual cash flow from financing activities is -$13.14 million

Quarterly CAPEX

$6.20 M
+$4.61 M+290.61%

September 1, 2024

Summary

Performance

3-Month Change

+290.61%

1-Year Change

+929.73%

3-Year Change

+2837.91%

5-Year Change

+2837.91%

RNAC Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.97%
RNAC quarterly capital expenditures is higher than 73.97% of companies in Healthcare sector

High & Low

All-time High

$6.20 M
RNAC quarterly capital expenditures is currently at an all-time high

3-Year Low

$0.00
RNAC quarterly capital expenditures is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
RNAC previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
RNAC next earnings announcement is scheduled for Mar 7, 2025

OtherRNACcash flowmetrics:

Quarterly FCF

$7.49 M
RNAC quarterly free cash flow is $7.49 million

Quarterly CFO

$13.69 M
RNAC quarterly cash flow from operations is $13.69 million

Quarterly CFI

-$6.20 M
RNAC quarterly cash flow from investing activities is -$6.20 million

Quarterly CFF

$124.49 M
RNAC quarterly cash flow from financing activities is $124.49 million

TTM CAPEX

$8.45 M
+$6.20 M+275.14%

September 1, 2024

Summary

Performance

3-Month Change

+275.14%

1-Year Change

+1146.61%

3-Year Change

+603.75%

5-Year Change

+603.75%

RNAC TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.76%
RNAC TTM capital expenditures is higher than 61.76% of companies in Healthcare sector

High & Low

All-time High

$8.45 M
RNAC TTM capital expenditures is currently at an all-time high

3-Year Low

$206.00 K
RNAC TTM capital expenditures is currently +4002.91% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
RNAC previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
RNAC next earnings announcement is scheduled for Mar 7, 2025

OtherRNACcash flowmetrics:

TTM FCF

-$48.41 M
RNAC TTM free cash flow is -$48.41 million

TTM CFO

-$39.96 M
RNAC TTM cash flow from operations is -$39.96 million

TTM CFI

-$1.89 M
RNAC TTM cash flow from investing activities is -$1.89 million

TTM CFF

$181.73 M
RNAC TTM cash flow from financing activities is $181.73 million

RNAC CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-82.8%+929.7%+1146.6%
3 y3 years-74.7%+2837.9%+603.8%
5 y5 years-76.7%+2837.9%+603.8%

RNAC CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-82.8%at lowat high-100.0%at high+4002.9%
5 y5-year-82.8%+338.3%at high-100.0%at high>+9999.0%
alltimeall time-82.8%+338.3%at high-100.0%at high>+9999.0%

Cartesian Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$6.20 M(+290.6%)
$8.45 M(+275.1%)
Jun 2024
-
$1.59 M(+163.6%)
$2.25 M(+232.3%)
Mar 2024
-
$602.00 K(+840.6%)
$678.00 K(+229.1%)
Dec 2023
$206.00 K(-82.8%)
$64.00 K(>+9900.0%)
$206.00 K(-41.6%)
Sep 2023
-
$0.00(-100.0%)
$353.00 K(-55.3%)
Jun 2023
-
$12.00 K(-90.8%)
$789.00 K(-9.9%)
Mar 2023
-
$130.00 K(-38.4%)
$876.00 K(-27.1%)
Dec 2022
$1.20 M(+10.7%)
-
-
Dec 2022
-
$211.00 K(-51.6%)
$1.20 M(-5.3%)
Sep 2022
-
$436.00 K(+340.4%)
$1.27 M(+27.3%)
Jun 2022
-
$99.00 K(-78.2%)
$996.00 K(-34.3%)
Mar 2022
-
$455.00 K(+63.7%)
$1.51 M(+39.6%)
Dec 2021
$1.08 M(+33.1%)
$278.00 K(+69.5%)
$1.08 M(+8.8%)
Sep 2021
-
$164.00 K(-73.5%)
$997.00 K(-11.3%)
Jun 2021
-
$618.00 K(+2372.0%)
$1.12 M(+59.4%)
Mar 2021
-
$25.00 K(-86.8%)
$705.00 K(-13.5%)
Dec 2020
$815.00 K(+1634.0%)
$190.00 K(-34.7%)
$815.00 K(+23.1%)
Sep 2020
-
$291.00 K(+46.2%)
$662.00 K(+76.1%)
Jun 2020
-
$199.00 K(+47.4%)
$376.00 K(+106.6%)
Mar 2020
-
$135.00 K(+264.9%)
$182.00 K(+287.2%)
DateAnnualQuarterlyTTM
Dec 2019
$47.00 K(-94.7%)
$37.00 K(+640.0%)
$47.00 K(-87.6%)
Sep 2019
-
$5000.00(0.0%)
$378.00 K(-12.7%)
Jun 2019
-
$5000.00(-98.6%)
$433.00 K(-51.0%)
Dec 2018
$884.00 K(+20.6%)
$368.00 K(+513.3%)
$884.00 K(+32.9%)
Sep 2018
-
$60.00 K(-77.3%)
$665.00 K(-8.9%)
Jun 2018
-
$264.00 K(+37.5%)
$730.00 K(-15.8%)
Mar 2018
-
$192.00 K(+28.9%)
$867.00 K(+18.3%)
Dec 2017
$733.00 K(+25.1%)
$149.00 K(+19.2%)
$733.00 K(+5.9%)
Sep 2017
-
$125.00 K(-68.8%)
$692.00 K(-17.9%)
Jun 2017
-
$401.00 K(+591.4%)
$843.00 K(+68.3%)
Mar 2017
-
$58.00 K(-46.3%)
$501.00 K(-14.5%)
Dec 2016
$586.00 K(-49.6%)
$108.00 K(-60.9%)
$586.00 K(-3.9%)
Sep 2016
-
$276.00 K(+367.8%)
$610.00 K(-24.9%)
Jun 2016
-
$59.00 K(-58.7%)
$812.00 K(-31.4%)
Mar 2016
-
$143.00 K(+8.3%)
$1.18 M(+1.7%)
Dec 2015
$1.16 M(+412.3%)
$132.00 K(-72.4%)
$1.16 M(+12.8%)
Sep 2015
-
$478.00 K(+11.2%)
$1.03 M(+86.4%)
Jun 2015
-
$430.00 K(+249.6%)
$553.00 K(+349.6%)
Mar 2015
-
$123.00 K
$123.00 K
Dec 2014
$227.00 K
-
-

FAQ

  • What is Cartesian Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Cartesian Therapeutics?
  • What is Cartesian Therapeutics annual CAPEX year-on-year change?
  • What is Cartesian Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Cartesian Therapeutics?
  • What is Cartesian Therapeutics quarterly CAPEX year-on-year change?
  • What is Cartesian Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Cartesian Therapeutics?
  • What is Cartesian Therapeutics TTM CAPEX year-on-year change?

What is Cartesian Therapeutics annual capital expenditures?

The current annual CAPEX of RNAC is $206.00 K

What is the all time high annual CAPEX for Cartesian Therapeutics?

Cartesian Therapeutics all-time high annual capital expenditures is $1.20 M

What is Cartesian Therapeutics annual CAPEX year-on-year change?

Over the past year, RNAC annual capital expenditures has changed by -$995.00 K (-82.85%)

What is Cartesian Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of RNAC is $6.20 M

What is the all time high quarterly CAPEX for Cartesian Therapeutics?

Cartesian Therapeutics all-time high quarterly capital expenditures is $6.20 M

What is Cartesian Therapeutics quarterly CAPEX year-on-year change?

Over the past year, RNAC quarterly capital expenditures has changed by +$5.60 M (+929.73%)

What is Cartesian Therapeutics TTM capital expenditures?

The current TTM CAPEX of RNAC is $8.45 M

What is the all time high TTM CAPEX for Cartesian Therapeutics?

Cartesian Therapeutics all-time high TTM capital expenditures is $8.45 M

What is Cartesian Therapeutics TTM CAPEX year-on-year change?

Over the past year, RNAC TTM capital expenditures has changed by +$7.77 M (+1146.61%)